Malpractice & Allegations of Misconduct

Pharmaceutical Communications takes allegations of misconduct and malpractice very seriously whenever brought to the attention of the journal (both pre-publication and post-publication). The journal resolves all such issues in the light of COPE recommendation provided at the following link;

All cases of misconduct are dealt with by the ‘Complaint Redressal & Appellate Committee’, which can be reached at the following email address.